21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
COMPOUNDS USEFUL FOR INHIBITING CHK1
#12302VETERINARY COMPOSITIONS FOR TREATING MASTITIS
#12303BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF
#12304Ophthalmic composition
#12305Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
#12306Therapies for acute renal failure
#12307ULTRA LOW DOSE DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS
#12308Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof
#12309Nutritional composition with improved digestibility
#12310Nutritional composition to promote healthy development and growth
#12311Method Of Treating Demyelinating Central Nervous System Diseases
#12312Use of chitosans for the treatment of nail inflammatory diseases
#12313TREATMENT OF CHRONIC RENAL FAILURE AND OTHER CONDITIONS IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS
#12314REHYDRATION COMPOSITION FOR PREPARING A SOLUTE BY RECONSTITUTION IN WATER
#12315DISCONTINUOUS METHODS OF TREATING CANCER
#12316Targeting cancer therapy combination
#12317Compositions and Methods for Treating or Preventing Ophthalmic Disease
#12318Hydrophilic foam and pharmaceutical dosage form employing the same
#12319Bupropion hydrobromide and therapeutic applications
#12320EXTENDED RELEASE ORAL ACETAMINOPHEN/TRAMADOL DOSAGE FORM
#12321COMBINATION THERAPY USING PHOSPHODIESTERASE INHIBITORS
#12322TREATING ADHD AND OTHER DISEASES INVOLVING INFLAMMATION
#12323Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#12324Treatment of carcinomas with a combination of EGF-pathway and telomerase inhibitors
#12325METHOD AND COMPOSITION FOR TREATMENT OF NEOPLASMS
#12326Frizzled-binding agents and uses thereof
#12327Semaphorin 7A plays a critical role in TGF-β-induced pulmonary fibrosis and alveolar destruction
#12328PHARMACEUTICAL COMPOSITION
#12329ANTITUMOR COMBINATION COMPRISING A MORPHOLINYL ANTHRACYCLINE AND AN ANTIBODY
#12330COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER
#12331ANTIBIOTIC SYNERGISM
#12332Treatment of cancer with glufosfamide in patients not receiving insulin therapy
#12333TOPICAL COMPOSITION FOR THE TREATMENT OF ALLERGENIC EFFECTS
#12334Nutritional composition to promote healthy development and growth
#12335Method for preventing and treating cardiovascular diseases with BRCA1
#12336METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS
#12337Beneficial effects of bacteriophage treatments
#12338HYDRAZIDO-PEPTIDES AS INHIBITORS OF HCV NS3-PROTEASE
#12339Use of alpha-hydroxy carbonyl compounds as reducing agents
#12340Uterine stimulant sticks
#12341METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITIS
#12342Topical NSAID compositions having sensate component
#12343Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
#12344COMBINATION THERAPY
#12345Regenerative wound healing using copper-silver citrate composition
#12346Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines
#12347METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#12348NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#12349AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases
#12350Methods and Compositions Using Immunomodulatory Compounds for The Treatment and Management of Cancers and Other Diseases
#12351Method for treating pulmonary arterial hypertension
#12352HYDROGENATED PYRIDO (4,3-B) INDOLES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#12353NEW COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
#12354PHENOTHIAZINE MODULATORS OF H1 RECEPTOR AND D2 RECEPTOR
#12355PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS
#12356NASAL SPRAY COMPOSITION AND METHOD FOR TREATING RHINITIS, SINUSITIS OR BOTH
#12357Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing Them
#12358Compositions containing PUFA and methods of use thereof
#12359TGF-BETA STIMULANT AND FURTHER AGENT TO REDUCE SIDE EFFECTS
#12360Immunocompetent xenograft model
#12361Hydrous gel and production process and use of the hydrous gel
#12362Method for treating cystic fibrosis
#12363Wound healing
#12364Casein complexes
#12365Effective use method of medicaments and method of preventing expression of side effect
#12366Chaperonin 10 immunosuppression
#12367PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE FOR THE PREVENTION AND TREATMENT OF HYPOXIC INJURY
#12368COMPOSITION FOR TREATING XEROSTOMIA OR DRY MOUTH
#12369Combination herbal product to benefit respiratory tract
#12370FORMULATION CONTAINING A CARBOXYLIC ACID OR AN ESTER THEREOF
#12371Appetite suppressant composition
#12372COMPOSITIONS AND METHODS FOR PROPHYLACTIC AND THERAPEUTIC SUPPLEMENTATION OF NUTRITION IN SUBJECTS
#12373SIROLIMUS PHARMACEUTICAL FORMULATIONS
#12374Abuse-Resistant Dosage Form
#12375Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent
#12376COMPOSITIONS AND METHODS FOR TREATING PERIODONTAL DISEASE COMPRISING CLONIDINE, SULINDAC AND/OR FLUOCINOLONE
#12377Substance preventing adverse actions of therapeutic agents for dyslipidemia
#12378ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS
#1237927877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
#12380Monoclonal antibodies that recognize epitopes of amyloid-beta
#12381METHOD OF TREATING ANDROGEN INDEPENDENT PROSTATE CANCER
#12382Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
#12383Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#12384COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT
#12385PHARMACEUTICAL COMPOSITION
#12386Methods and devices for epithelial protection during photodynamic therapy
#12387Synergistic anti-inflammatory and antioxidant dietary supplement compositions
#12388BONE GRAFT COMPOSITES AND METHODS OF TREATING BONE DEFECTS
#12389COMPOSITION FOR PREVENTION OR TREATMENT OF BONE MARROW DAMAGE
#12390Oncolytic Adenoviruses and Uses Thereof
#12391Method of cancer treatment
#12392Method of treating tuberculosis with interferons
#12393Method of Treating Cancer with Immunomodulatory Compounds and IgG
#12394TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN
#12395FORMULATION AND METHOD FOR THE TREATMENT OF FUNGAL NAIL INFECTIONS
#12396Method of determining a phosphorus binder dosage for a dialysis patient
#12397Passenger conveyor handrail drive control strategy
#12398USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS
#12399HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS
#12400TREATMENT OF INSULIN RESISTANCE OR DISEASES ASSOCIATED WITH INSULIN RESISTANCE
#12401Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
#12402Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
#12403Oligomeric compounds for the modulation of HIF-1alpha expression
#12404Modulation of insulin like growth factor I receptor expression in cancer
#12405METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS
#12406Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
#12407Compositions for treatment of common cold
#12408METHODS FOR TREATING OR PREVENTING SYMPTOMS OF HORMONAL VARIATIONS
#12409Ketoconazole enantiomer in humans
#12410Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
#12411Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors
#12412Two-component pharmaceutical composition for the treatment of pain
#12413COMBINATION THERAPY COMPRISING ANGIOTENSIN RECEPTOR BLOCKERS AND VASOPRESSIN RECEPTOR ANTAGONISTS
#12414PIPERIDINYL-PIPERIDINE AND PIPERAZINYL-PIPERIDINE FOR USE IN THE TREATMENT OF DIABETES OR PAIN
#12415Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
#12416Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
#12417Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction
#12418DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#12419Compositions and methods of the treatment of obesity and osteoporosis
#12420PAIN RELIEVING PATCH
#12421SALTS OF HIV INHIBITOR COMPOUNDS
#12422Compositions useful for reducing nephrotoxicity and methods of use thereof
#12423Preservative System for Emulsion-Based Therapeutic Topical Formulations
#12424Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders
#12425TREATMENT OF MACULAR DEGENERATION-RELATED DISORDERS
#12426MGMT inhibitor combination for the treatment of neoplastic disorders
#12427PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES IN DISEASE
#12428Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage
#12429Novel Composition for Tumor Growth Control
#12430ROMIDEPSIN-BASED TREATMENTS FOR CANCER
#12431USE OF ORGANIC COMPOUNDS
#12432Methods to impair hematologic cancer progenitor cells and compounds related thereto
#12433Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
#12434Composition comprising the extract of combined herbs for preventing and treating liver disease
#12435Topical hair care formulation and method of making
#12436Weight reducing composition
#12437Medicament for treating lung cancer
#12438Topical compositions containing magaldrate
#12439HEMOSTATIC BIO-MATERIAL COMPOSITION AND METHOD
#12440SUSTAINED-RELEASE DRUG DELIVERY COMPOSITIONS AND METHODS
#12441Methods of using substance P to promote healing of vascular wounds
#12442Solid preparation comprising alogliptin and pioglitazone
#12443Novel Triclosan Salts
#12444Alpha Thymosin Peptides as Cancer Vaccine Adjuvants
#12445METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER
#12446Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation
#12447Combination treatment of CD38-expressing tumors
#12448Compositions and methods for treatment of viral diseases
#12449Treatment method using EGFR antibodies and SRC inhibitors and related formulations
#12450Pharmaceutical combinations
#12451Anti-phospho-Akt antibodies
#12452ANTAGONISTS OF A NON-SELECTIVE CATION CHANNEL IN NEURAL CELLS
#12453COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY
#12454TREATMENT OF GRAFT-VERSUS-HOST DISEASE
#12455Remedy For Chemotherapy-Resistant Cancer Containing HLA Class I-Recognizing Antibody as the Active Ingredient and Use of the Same
#12456NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS
#12457Replenishment and enrichment of ocular surface lubrication
#12458Combination enzyme therapy for digestion of dietary gluten
#12459Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
#12460METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#12461Platelet rich plasma formulations for cardiac treatments
#12462Use of nitrites and nitrates and compositions containing these
#12463ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES
#12464Systems, Methods, and Compositions for Treatment and Use of a Palatal Patch
#12465Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
#12466Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas
#12467USE OF DIMETHYL SULFONE (MSM) TO REDUCE HOMOCYSTEINE LEVELS
#12468Method of treating cancer with an RPN2 gene expression inhibitor
#12469Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex
#12470PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TEMOZOLOMIDE AND MULTI-TARGETED KINASE INHIBITORS
#12471USE OF BIOTIN TO PREVENT PHOTOAGING
#12472METHOD FOR IMPROVING THE PHARMACOKINETICS OF DRUGS METABOLIZED BY UGT2B10
#12473Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
#12474HIF-1 Inhibitors
#12475Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
#12476Buprenorphine-wafer for drug substitution therapy
#12477Compositions useful as inhibitors of protein kinases
#12478Organic compounds
#12479Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
#12480COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID
#12481FOOD SUPPLEMENTATION COMPOSITION CONTAINING ONE OR MORE VITAMIN D3 COMPOUNDS AND ONE OR MORE MAGNESIUM SALTS
#12482METHOD OF TREATING AND PREVENTING HYPERPARATHYROIDISM WITH ACTIVE VITAMIN D ANALOGS
#12483Topical treatment of skin infection
#12484USE OF 9-OXOACRIDINE-10-ACETIC ACID, SALTS AND ESTERS THEREOF IN COMBINATION THERAPY OF OVARIAN CANCER
#12485Methods and compositions of inhibiting complement and cellular activation with Dextran Sulfate
#12486TREATMENT OF INFLAMMATORY BOWEL DISEASE
#12487Topical use of Levofloxacin for reducing lung inflammation
#12488Modulation of synaptogenesis
#12489Pharmaceutical Compositions of Hglp-1, Exendin-4 and Analogs Thereof
#12490FEED OR FOOD PRODUCTS COMPRISING FUNGAL MATERIAL
#12491Methods and formulations for treating chronic liver disease
#12492Capsaicinoid decontamination compositions and methods of use
#12493METHODS FOR TREATING SKIN LESIONS
#12494COLON CLEANSING COMPOSITIONS AND METHODS
#12495Dosage forms of bisphosphonates
#12496CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE
#12497METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES
#12498ANTITUMOR AGENT
#12499ANTIBODY AND USES THEREOF
#12500ANTICANCER AGENT COMPRISING ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY
#12501Use of anti-IL-20 antibody for treating osteoporosis
#12502METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES
#12503COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS
#12504POTENTIATION OF ERYTHROPOIETIN (EPO) ACTION BY MEMBRANE STEROID RECEPTOR AGONISTS
#12505CELLULAR PREPARATIONS FOR USE AS A REVASCULARIZATION STIMULATING AGENT
#12506Treatment of Hepatitis C Infection With Metalloporphyrins
#12507Enhancement of B cell proliferation by IL-15
#12508METHOD OF MULTIDETECTOR COMPUTED TOMAGRAPHY
#12509Platelet Additive Solution For Leukoreducing White Blood Cells In Apheresed Platelets
#12510Composition and method to modify sperm function and increase male gender ratio in mammals
#12511Memantine For The Treatment Of Childhood Behavioral Disorders
#12512COMPOSITION AND METHOD FOR NEUROPROTECTION AGAINST EXCITOTOXIC INJURY
#12513COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS
#12514COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#12515Isoform of bruton's tyrosine kinase (BTK) protein
#12516COMPOSITION COMPRISING AT LEAST ONE PPAR AGONIST AND A LIPID COMPONENT
#12517METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING AGE-RELATED DISEASES
#12518Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
#12519CB-1 RECEPTOR MODULATOR PHARMACEUTICAL FORMULATIONS
#12520PHARMACEUTICAL COMPOSITION COMPRISING FERMENTED GINSENG
#12521METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS
#12522Heparin Compositions and Selectin Inhibition
#12523NOVEL TELLURIUM COMPOUNDS AND THEIR USE AS IMMUNOMODULATORS
#12524Dietary composition and method of using the same
#12525Anti-hypothermia composition
#12526Method and composition for postoperative wound healing
#12527DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME
#12528Method for reducing the risk of spontaneous abortion in a human female subject
#12529Cinnamomi and poria composition, method to prepare same and uses thereof
#12530Energy Compositions
#12531Preparation of a therapeutic composition
#12532Methods and Compositions for Treating Viral Hemorrhagic Fever
#12533THERAPY PROCEDURE FOR DRUG DELIVERY FOR TRIGEMINAL PAIN
#12534Alginate and alginate lyase compositions and methods of use
#12535Preventing transfusion related complications in a recipient of a blood transfusion
#12536Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
#12537Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
#12538Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists
#12539Formulation containing phosphate derivatives of electron transfer agents
#12540Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes
#12541Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
#12542Therapeutic agent for inflammatory bowel disease and TNF-α production inhibitor
#12543Therapeutic agent for urinary excretion disorder
#12544Transdermal drug delivery using an osmolyte and vasoactive agent
#12545Adjuvant chemotherapy for anaplastic gliomas
#12546Pharmaceutical compositions containing plasma protein
#12547Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions and Pharmaceutical Compositions
#12548GRAM-POSITIVE CARBAPENEM ANTIBACTERIALS AND PROCESSES FOR THEIR PREPARATION
#12549CANCER TREATMENT METHOD
#12550Hyperthermic technologies and therapeutic uses thereof
#12551Targeted therapeutic proteins
#12552Cellular factor-containing solution compositions
#12553Use of Nutritional Compositions for Preventing Disorders
#12554Method of treatment and prevention of metabolic and digestion disorders and of pathological states associated therewith and products used therein
#12555Methods for treating glioblastoma with herbal compositions
#12556NOVEL AGENTS FOR THE TREATMENT OF DISORDERS CONNECTED TO IMPAIRED NEUROTRANSMISSION
#12557THIOXANTHENE MODULATORS OF DOPAMINE D2 RECEPTORS
#12558METHOD OF CONTROLLING BLOOD SUGAR LEVELS, INSULIN LEVELS, CHOLESTEROL LEVELS, BODY FAT LEVELS, AND BODY WEIGHT BY ADMINISTERING A NUTRIENT FIBER MATRIX
#12559Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)
#12560Super brown cream
#12561High-loading, controlled-release magnesium oral dosage forms and methods of making and using same
#12562Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity
#12563Anti-diabetic combinations
#12564Pharmaceutical composition and administration thereof
#12565HARMINE COMPOUNDS FOR PROMOTING BONE GROWTH
#12566MEDICAL IMPLANTS WITH A COMBINATION OF COMPOUNDS
#12567Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides
#12568Combinations for the treatment of cancer
#12569Methods for human allografting
#12570Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
#12571MULTIPLE NEBULIZER SYSTEMS
#12572COMPOSITION FOR IMPROVING SKIN QUALITY AND A PROCESS FOR PREPARING THE SAME
#12573Calcium phosphate delivery vehicles for osteoinductive proteins
#12574Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells
#12575Probiotic infant products
#12576Compositions Comprising Kakadu Plum Extract Or Acai Berry Extract
#12577Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
#12578APPARATUS AND METHOD TO DISPENSE HPC-BASED VISCOUS LIQUIDS INTO POROUS SUBSTRATES, E.G., CONTINUOUS WEB-BASED PROCESS
#12579Pharmaceutical Composition Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and Paracetamol
#12580ANTI-TUMOR COMPOSITION
#12581Gel useful for the delivery of ophthalmic drugs
#12582COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#12583ANESTHESIA INDUCTION AND MAINTENANCE DRUG
#12584CANCER TREATMENT METHOD
#12585ACYCLOVIR FORMULATIONS
#12586Treatment of Behavioral Disorders
#12587Combination therapy
#12588Combination of HMG-COA Reductase Inhibitors with Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Pulmonary Disease
#12589SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS
#12590Formoterol/steroid bronchodilating compositions and methods of use thereof
#12591PHARMACEUTICAL COMPOSITIONS OF AN SRC KINASE INHIBITOR AND AN AROMATASE INHIBITOR
#12592Prevention and Treatment of Ophthalmic Complications of Diabetes
#12593Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
#12594Pharmaceutical composition for treatment of chronic liver diseases and use thereof
#12595SYNERGISM OF GOS AND POLYFRUCTOSE
#12596Combination of an HDAC inhibitor and an antimetabolite
#12597Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#12598Composition for maintaining gastrointestinal homeostasis
#12599Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
#12600Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent